First-in-Human Safety Study for Fractomer™ Biomatrix
NCT: NCT07151638 · SUSPENDED
Brief Summary
The goal of this clinical trial is to evaluate the safety of implanting a new medical device (Fractomer™ Biomatrix) in healthy volunteers. The main question it aims to answer is: How do healthy volunteers react to this injectable implant? Participants will receive a subcutaneous injection of Fractomer and their health will be monitored. After the monitoring period, the implant will be removed.
Frequently Asked Questions
What is First-in-Human Safety Study for Fractomer™ Biomatrix?
First-in-Human Safety Study for Fractomer™ Biomatrix is a clinical trial registered under NCT07151638. Current status: SUSPENDED.
What is the status of NCT07151638?
The current status of NCT07151638 (First-in-Human Safety Study for Fractomer™ Biomatrix) is: SUSPENDED.
When did First-in-Human Safety Study for Fractomer™ Biomatrix start?
First-in-Human Safety Study for Fractomer™ Biomatrix started on 2025-08-11.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.